That’s News

A New Combination Therapy for HER2-Positive Metastatic Breast Cancer

The recent FDA approval of the drug Tukysa (tucatinib) for use with the chemotherapeutic agents trastuzumab and capecitabine...


Researchers: Risk-Takers Needed to Fuel R&D

Individuals who are inclined to take risks are more likely to make decisions that lead to innovation, a key factor that companies should consider as they seek to jumpstart research and development — and economic growth — in the wake of the COVID-19 virus.

Coding for Virtual Visits

New CMS rules and waivers expanding the use of telemedicine in response to the COVID-19 pandemic have left providers with questions about coding and billing.

Case Studies: Direct Primary Care Pioneers

Direct primary care (DPC) offers physicians and patients an alternative to fee-for-service care involving third-party payers. Two physicians who have been immersed in DPC for years say it has allowed them to get back to the basics of medicine — and that patients’ response proves it is a force to be reckoned with.

New Drug Therapy Shows Promise for Cystic Fibrosis

An FDA-approved drug cocktail may provide improvement for many patients with this common hereditary disease.